ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,149Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 890

$1.05M Total Retail Price of All Prescriptions

Rank: 45 out of 890

492 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

28% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 17,904 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 781 586 S3 1 3
FUROSEMIDE 708 651 2 7
LEVOTHYROXINE SODIUM 533 524 3 2
GABAPENTIN 494 428 4 12
PRAVASTATIN SODIUM 446 429 5 10
OMEPRAZOLE 435 361 6 8
AMLODIPINE BESYLATE 432 415 7 1
METOPROLOL TARTRATE 399 334 8 15
TRAZODONE HCL 362 267 9 40
POTASSIUM CHLORIDE 330 291 10 11
DONEPEZIL HCL 313 309 11 30
TRAMADOL HCL 306 281 12 16
LISINOPRIL 293 256 13 4
SIMVASTATIN 289 277 14 5
NAMENDA 284 279 15 36
METOPROLOL SUCCINATE 264 245 16 17
PANTOPRAZOLE SODIUM 248 235 17 34
CLOPIDOGREL 234 227 18 28
LOSARTAN POTASSIUM 228 199 19 29
RANITIDINE HCL 226 210 20 49
GLIMEPIRIDE 219 210 21 27
DOXAZOSIN MESYLATE 212 212 22 70
SERTRALINE HCL 209 182 23 26
METFORMIN HCL ER 202 183 24 54
FLUOXETINE HCL 202 175 24 63
METHYLPREDNISOLONE 200 175 26 109
BENAZEPRIL HCL 198 198 27 44
ENALAPRIL MALEATE 182 180 28 56
PREDNISONE 182 147 28 47
ALLOPURINOL 172 172 30 31
WARFARIN SODIUM 168 168 31 24
EXELON 164 164 32 113
ALENDRONATE SODIUM 164 140 32 38
TAMSULOSIN HCL 162 158 34 32
PLAVIX 159 150 35 42
CYCLOBENZAPRINE HCL 153 111 R 36 64
HYDROCHLOROTHIAZIDE 150 142 37 9
ATORVASTATIN CALCIUM 146 127 38 13
DIOVAN HCT 144 144 39 48
DIOVAN 140 125 40 33
ESTRADIOL 133 98 R 41 118
CIPROFLOXACIN HCL 130 117 42 58
LOSARTAN-HYDROCHLOROTHIAZIDE 129 89 43 57
CYMBALTA 124 89 44 45
AMITRIPTYLINE HCL 119 90 R 45 43
BUPROPION HCL 117 116 46 366
NEXIUM 115 98 47 14
AZITHROMYCIN 114 96 48 37
SYNTHROID 109 109 49 53
TRIAMTERENE-HYDROCHLOROTHIAZID 107 91 50 237
PRAMIPEXOLE DIHYDROCHLORIDE 106 100 51 175
METFORMIN HCL 103 102 52 6
FENTANYL 100 76 S2 53 151
BUPROPION HCL SR 100 87 53 216
CEFUROXIME 93 79 55 168
SOTALOL 92 92 56 269
QUETIAPINE FUMARATE 89 89 57 73
LANTUS 89 83 57 50
TRICOR 89 89 57 98
DIGOXIN 82 82 60 65
CLONAZEPAM 82 71 60 202
ABILIFY 80 57 62 172
ATENOLOL 77 73 63 23
LYRICA 77 57 63 71
CITALOPRAM HBR 77 74 63 20
PREMARIN 76 75 R 66 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 70 66 21
IPRATROPIUM-ALBUTEROL 76 76 66 193
CARVEDILOL 74 74 69 22
TRIAMTERENE-HCTZ 74 53 69 61
ZOLPIDEM TARTRATE 73 61 71 19
PROPRANOLOL HCL 72 72 72 141
FLUTICASONE PROPIONATE 71 58 73 39
DOXYCYCLINE HYCLATE 70 66 74 89
CLONIDINE HCL 69 48 75 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 61 76 76
MELOXICAM 64 40 77 18
TERAZOSIN HCL 64 41 77 142
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 51 77 179
NYSTATIN 63 61 80 173
BUSPIRONE HCL 61 54 81 133
LOVASTATIN 60 60 82 46
KLOR-CON M20 59 59 83 72
AMIODARONE HCL 59 59 83 206
DEXILANT 59 39 83 138
FLUCONAZOLE 59 48 83 155
PROMETHAZINE HCL 55 53 R 87 104
AMOX TR-POTASSIUM CLAVULANATE 55 48 87 132
MIRTAZAPINE 55 51 87 82
METHOCARBAMOL 54 30 R 90 185
DIVALPROEX SODIUM 53 37 91 126
BUPROPION XL 53 53 91 190
ISOSORBIDE MONONITRATE ER 53 52 91 60
METOCLOPRAMIDE HCL 52 39 94 125
NIFEDIPINE ER 52 29 94 75
METOLAZONE 51 51 96 217
LEVETIRACETAM 51 31 96 137
FINASTERIDE 51 44 96 108
LANTUS SOLOSTAR 50 50 99 102
INSULIN SYRINGE 50 49 99 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.